Presentation TCT 2017 Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers! Presenter: Uzoma Ibebuogu October 30, 2017
Presentation TCT 2017 Point A Tiered Centers of Excellence Approach Makes Sense! Presenter: Patrick T. O'Gara October 30, 2017
Presentation TCT 2017 Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume! Presenter: Martin B. Leon October 30, 2017
Presentation TCT 2017 Point - Clearly, The More You Do, The Better You Are! Presenter: John D. Carroll October 30, 2017
Presentation TCT 2017 Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study Presenter: Robert O. Bonow, Michael J. Mack, David A. Wood October 30, 2017
Presentation TCT 2017 Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept Presenter: Robert O. Bonow, Michael J. Mack, Philippe Genereux October 30, 2017
Presentation TCT 2017 Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance Presenter: Robert O. Bonow, Michael J. Mack, Elazer R. Edelman October 30, 2017
Presentation TCT 2017 Slovakia Presents: Case Conclusion - How I Treated This Case Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova October 30, 2017
Presentation TCT 2017 Germany Comments: How Would I Treat This Case and Why? Presenter: Petr Kala, Jochen Wöhrle, Thomas Walther October 30, 2017
Presentation TCT 2017 Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova October 30, 2017
Presentation TCT 2017 Poland Presents: Case Conclusion - How I Treated This Case Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek October 30, 2017
Presentation TCT 2017 Czech Republic Comments: How Would I Treat This Case and Why? Presenter: Petr Kala, Jochen Wöhrle, Marian Branny October 30, 2017
Presentation TCT 2017 Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek October 30, 2017
Presentation TCT 2017 Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes Presenter: Petr Kala, Jochen Wöhrle, Martin Hudec October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis? Presenter: David H. Adams, Ted Feldman, Allan Schwartz October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR? Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani October 30, 2017
Presentation TCT 2017 TAVR Patient Journey V: Addressing Complications and Follow-up Presenter: Martina Kelly Speight, Amy E. Simone October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis? Presenter: David H. Adams, Ted Feldman, Craig R. Smith October 30, 2017
Presentation TCT 2017 TAVR Patient Journey IV: The Hospital Experience Presenter: Martina Kelly Speight, Sandra Lauck October 30, 2017
Presentation TCT 2017 TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis! Presenter: A. Pieter Kappetein October 30, 2017